Release Date: 27/08/18 07:56 Summary: Clarification - Continued success paves way for upgrade Price Sensitive: No Download Document 2.06MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%